PATENT CLAIM ANALYSIS

Application Number: 16183562
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.

Claim (Index 56):
A method for preparing the nanoemulsion formulation of the cyclosporine of  claim 35 , comprising:\n (a) forming an emulsion base by suspending a cyclosporine in a mixture of oil, solvent, surfactant, and water or buffer to form an emulsion base, and (b) homogenizing the emulsion base to form (i) particles of the cyclosporine in suspension, (ii) cyclosporine solubilized in the water or buffer, and (iii) oil droplets comprising solubilized cyclosporine.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.29412
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12007902', '14623150', '15142709', '15051654', '15546205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6530761694909474
- 35 USC 102 Novelty (BERT): 0.5720072660683139
- Combined Prediction Score: 0.6449692791486841
- Mean Citation Score: 260.95227800000004
- Max Citation Score: 461.69586
- Similarity Product: 364.1755678242445

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test